BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 26976797)

  • 1. Cannabidiol and epilepsy: Rationale and therapeutic potential.
    Leo A; Russo E; Elia M
    Pharmacol Res; 2016 May; 107():85-92. PubMed ID: 26976797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?
    Lippiello P; Balestrini S; Leo A; Coppola A; Citraro R; Elia M; Russo E; De Sarro G
    Curr Pharm Des; 2016; 22(42):6426-6433. PubMed ID: 27587196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
    Reddy DS; Golub VM
    J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytocannabinoids and epilepsy.
    dos Santos RG; Hallak JE; Leite JP; Zuardi AW; Crippa JA
    J Clin Pharm Ther; 2015 Apr; 40(2):135-43. PubMed ID: 25475762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case for assessing cannabidiol in epilepsy.
    Cilio MR; Thiele EA; Devinsky O
    Epilepsia; 2014 Jun; 55(6):787-90. PubMed ID: 24854434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).
    Klein BD; Jacobson CA; Metcalf CS; Smith MD; Wilcox KS; Hampson AJ; Kehne JH
    Neurochem Res; 2017 Jul; 42(7):1939-1948. PubMed ID: 28478594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol as potential treatment in refractory pediatric epilepsy.
    Paolino MC; Ferretti A; Papetti L; Villa MP; Parisi P
    Expert Rev Neurother; 2016; 16(1):17-21. PubMed ID: 26567560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights.
    Lazarini-Lopes W; Do Val-da Silva RA; da Silva-Júnior RMP; Leite JP; Garcia-Cairasco N
    Neurosci Biobehav Rev; 2020 Apr; 111():166-182. PubMed ID: 31954723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
    Reddy DS
    Clin Pharmacol Ther; 2017 Feb; 101(2):182-184. PubMed ID: 27506704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances.
    Farrelly AM; Vlachou S; Grintzalis K
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V; Reddy DS
    Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
    Hess EJ; Moody KA; Geffrey AL; Pollack SF; Skirvin LA; Bruno PL; Paolini JL; Thiele EA
    Epilepsia; 2016 Oct; 57(10):1617-1624. PubMed ID: 27696387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy.
    Boleti APA; Frihling BEF; E Silva PS; Cardoso PHO; de Moraes LFRN; Rodrigues TAA; Biembengute MEF; Koolen HHF; Migliolo L
    Neurosci Biobehav Rev; 2022 Jan; 132():1214-1228. PubMed ID: 33031814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol for treatment of refractory childhood epilepsies: Experience from a single tertiary epilepsy center in Slovenia.
    Neubauer D; Perković Benedik M; Osredkar D
    Epilepsy Behav; 2018 Apr; 81():79-85. PubMed ID: 29526578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol in canine epilepsy.
    Potschka H; Bhatti SFM; Tipold A; McGrath S
    Vet J; 2022 Dec; 290():105913. PubMed ID: 36209995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy.
    Geffrey AL; Pollack SF; Bruno PL; Thiele EA
    Epilepsia; 2015 Aug; 56(8):1246-51. PubMed ID: 26114620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research.
    Franco V; Bialer M; Perucca E
    Neuropharmacology; 2021 Mar; 185():108442. PubMed ID: 33347884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.